[Adrenergic beta agonists (adrenaline, dopamine, dobutamine, salbutamol); beta-blockers. Fundamentals and rules of use].
Service de pharmacologie, groupe hospitalier Pitié-Salpêtrière, Paris.
P
P
Lechat
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use; D000075202:Contraindications; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D014664:Vasodilation / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004280:Dobutamine; D000420:Albuterol; D004298:Dopamine; D004837:Epinephrine
Agonistes beta-adrénergiques (adrénaline, dopamine, dobutamine, salbutamol); beta-bloquants. Principes et règles d'utilisation.